- Workshop presentation
- Open Access
Cardiac T1 mapping in congenital heart disease: bolus versus infusion protocol for measurement of myocardial extracellular volume
© Al-Wakeel et al; licensee BioMed Central Ltd. 2015
- Published: 3 February 2015
- Congenital Heart Disease
- Cardiac Magnetic Resonance
- Right Ventricle
- German Research Foundation
- Congenital Heart Disease Patient
Measurement of myocardial extracellular volume fraction (ECV) with T1 mapping cardiac magnetic resonance (CMR) before and after the application of a gadolinium-based extracellular contrast agent enables the assessment of diffuse myocardial fibrosis. The equilibrium between blood and myocardium contrast concentration required for ECV measurements can be achieved with a primed contrast infusion (equilibrium contrast-CMR). In healthy volunteers it could be shown that a single bolus may also be sufficient to reach equilibrium. We hypothesized that equilibrium between blood and myocardium contrast distribution can be achieved with the bolus-only technique to accurately measure diffuse myocardial fibrosis in patients with congenital heart disease (CHD).
A study group of 23 patients with CHD (age range 14 - 45 years, mean age 25.8 years) was compared with 17 healthy volunteers (age range 23 - 30 years; mean age 25.1 years). Using modified Look-Locker inversion recovery (MOLLI) T1 mapping before application, 15 minutes after bolus injection, and during constant infusion of Gd-DOTA, T1 values were obtained for blood pool and myocardium of the interventricular septum (IVS), the left ventricular (LV) antero-/lateral wall, and the inferior or anterior wall of the right ventricle (RV) in a single midventricular plane in short axis or in transverse orientation.
Based on T1 mapping, ECV of LV and RV myocardium can be measured accurately by the bolus-only technique in patients with CHD. The use of a bolus-only approach facilitates the integration of ECV measurements into clinical CMR routine workflow across a wide range of CHD.
The study was funded by the German Research Foundation (DFG ME 3508/4).
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.